Company Analysis
Sign in

Rockwell Medical, Inc. (RMTI)

Nasdaq: RMTI · Pharmaceutical Preparations · Wixom, MI · filing with the SEC since 1997
Full chart Alerts Compare
Grade4.3
◀ Past 3.4● Present 5.3▶ Future 4.0
1 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Income statement, as filed

In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016
Report filedMar 26, 2026Mar 20, 2025Mar 21, 2024Mar 30, 2023Apr 8, 2022Mar 31, 2021Mar 17, 2020Mar 18, 2019Mar 15, 2018Mar 15, 2017
Revenue69,258,000101,489,00083,612,00072,810,00061,931,00062,197,00061,303,000r63,388,61757,300,28153,284,166
For lenders
Net interest income······367,077535,641r790,226·
Cost of revenue57,563,00084,005,00074,908,00068,733,00064,351,00059,472,00058,464,000r64,973,15753,598,39046,531,648
Gross profit11,695,00017,484,0008,704,0004,077,000-2,420,0002,725,0002,839,000r-1,584,5403,701,8916,752,518
Research and development019,0001,107,0003,119,0006,835,0007,092,0006,886,000r5,642,3176,321,4005,840,346
Selling, general and administrative·······23,082,30423,303,40921,120,901
Sales and marketing2,354,0002,749,0002,125,0002,094,0005,733,0007,871,0009,050,000r1,004,584··
General and administrative14,032,00014,108,00012,142,00015,644,00015,348,00016,182,00020,998,000r22,077,720··
Operating income-4,691,000608,000-6,670,000-16,780,000-30,336,000-28,420,000-34,525,000r-32,439,161-25,922,918-20,208,729
Interest expense1,124,0001,254,0002,301,0001,936,0002,360,0001,879,00025,000···
Interest and investment income234,00092,000211,00033,00022,000238,000392,000·892810,340
Other income (expense), net-623,000-1,088,000-1,769,000-1,899,000-2,338,000-2,470,000397,000r313,3031,634·
Income before income taxes-5,314,000-480,000-8,439,000·····-25,921,284-19,398,389
Income tax expense000000000404,527
Net income-5,314,000-480,000-8,439,000-18,679,000-32,674,000-30,890,000-34,128,000r-32,125,858-25,921,284-19,802,916
Net income to common shareholders-5,467,000-782,000-8,589,000-18,679,000······
Earnings per share, basic-0.15-0.03-0.37-1.31r-2.6414rb-3.1103b··-3.869b-2.9586b
Earnings per share, diluted-0.15-0.03-0.37-1.31r-2.6414rb-3.1103b··-3.869b-2.9586b
Earnings per share, basic and diluted·····-3.1103b-4.2483b-4.6276b-3.869b·
Weighted average shares, basic35,974,23131,058,53923,322,91514,304,512r12,362,970rb9,968,312b··6,731,613b6,680,042b
Weighted average shares, diluted35,974,23131,058,53923,322,91514,304,512r12,362,970rb9,968,312b··6,731,613b6,680,042b
Weighted average shares, basic and diluted·····9,968,312b8,030,172b6,963,228b6,731,613b·
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the change of share basis.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldus-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
us-gaap:SalesRevenueGoodsNet
Net interest income interest earned less interest paidus-gaap:InterestIncomeExpenseNet
Cost of revenue what it cost to make or buy what it soldus-gaap:CostOfGoodsAndServicesSold
us-gaap:CostOfGoodsSold
Gross profit revenue less the cost of what it soldus-gaap:GrossProfit
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
Selling, general and administrative the cost of selling and of running the companyus-gaap:SellingGeneralAndAdministrativeExpense
Sales and marketing the cost of finding and serving customersus-gaap:SellingAndMarketingExpense
General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest expense what its borrowing costus-gaap:InterestExpenseNonoperating
us-gaap:InterestExpense
Interest and investment income what its cash and investments earnedus-gaap:InvestmentIncomeNet
us-gaap:InvestmentIncomeInterest
us-gaap:InvestmentIncomeInterestAndDividend
Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Net income to common shareholders what is left for common shareholdersus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
SI Assistanton RMTI · research, not advice